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Abstract
Chromosome 22q11.2 deletion syndrome (22q11.2DS) is a result of a hemizygotic microdeletion
that results in a variety of impairments in children including greater risk for psychiatric ailments in
adulthood. We used high-resolution magnetic resonance imaging to accurately quantify the length
and, for the first time, volume, of cavum septum pellucidum (CSP) in children aged 7 to 14 years
with 22q11.2DS and typically developing (TD) controls. Significantly greater anteroposterior length
and greater CSP volumes were found in children with 22q11.2DS compared to controls. Furthermore,
the largest CSP were found only in the 22q11.2DS group and with a much higher incidence than
previously reported in the literature. Given the significant midline anomalies in the brains of those
affected by 22q11.2DS, large CSP may be a biomarker of atypical brain development. The
implication of these larger CSP for cognitive and behavioral development is a topic in need of further
investigation.
Keywords
genetic disorder; pediatric neuroimaging; brain volumetric methods; velocardiofacial syndrome
(VCFS); DiGeorge syndrome
1. Introduction
One of the earliest developmental processes in brain is the formation of the ventricular system
and the associated septum separating the two chambers (Galarza et al., 2004). Typically, from
the second to the fifth months of embryonic and fetal development, the lateral ventricles
elongate and expand laterally away from the midline along with the expansion of the cerebral
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cortex. The anterior, posterior, and inferior horns as well as the bodies of the lateral ventricles
become delineated and larger through the seventh month of development. The septum
pellucidum forms a medial wall between the body and the anterior horn of the lateral ventricles.
Incomplete fusion of the laminae can manifest as one or two separate cavities: a cavum septum
pellucidum (CSP) and a cavum vergae (CV).
Anatomically, the CSP is defined anteriorly by the genu of the corpus callosum, superiorly by
the body of the corpus callosum, posteriorly by the anterior limb and pillars of the fornix, and
inferiorly by the rostrum of the corpus callosum and the anterior commissure. In prenatal month
five, anterior to posterior and superior to inferior consolidation of the corpus callosum begins.
The rostrum of the corpus callosum links the genu and the lamina terminalis while the fornix
remains relatively stationary and the forceps minor grow to the frontal lobes by month seven.
As callosal consolidation occurs, the leaflets of the septum pellucidum are drawn together and
towards the lamina terminalis, closing the CSP from rostrum to fornix. Typically, the more
anterior CSP is separated from the posterior CV by the anterior columns of the fornix. If the
fornix is insufficiently fused with the corpus callosum, the CSP and CV will form into one
continuous cavity (Born et al., 2004). In 15% of typically developing (TD) infants, the laminae
fuse within one month post-partum, with the majority (85%) showing laminae fusion within
six months.
The mechanisms by which the septum pellucidum closes and by which a CSP is maintained
are still not completely understood (Shashi et al., 2004) but fusion of the laminae depends on
the normal development of surrounding structures, particularly the hippocampus and the corpus
callosum (Sarwar, 1989). Galarza and colleagues (2004) suggest several possible modulators
of CSP maintenance, including primary atrophy in the form of reduced frontal and temporal
lobe volumes and overall hemispheric volume reduction with ventricular enlargement. Support
for this mechanism includes the common clinical neuroimaging correlation of CSP with brain
anomalies characterized by global decrease in cerebral mass, such as in the pachygyria-
lissencephaly spectrum and non-specific microcephaly (personal observation, JP). The
proposal that laterally applied pressure, such as would be expected from increasing lobar
volumes in normal brain development, can close the CSP is suggested by the observation of
transient closure in a premature baby with hydrocephalus resulting from an intraventricular
bleed (Needelman et al., 2006). Reduced connectivity (with resultant decreased tractional force
exerted in an anterolateral direction) between the genu of the corpus callosum (the anterior
border of the septum pellucidum) and the frontal lobes might also result in the maintenance of
a CSP anteriorly. Since the corpus callosum also provides the superior attachment of the septum
pellucidum, aberrant development leading to more lateral displacement could also result in less
transmission of mass from superolateral cortical structures through the midline structures,
which could in turn lead to maintenance of a CSP as well. CSP has also been noted with
increased frequency in developmentally delayed individuals, suggesting it is commonly related
to cerebral dysgenesis of many types (Bodensteiner and Schaefer, 1997). Indeed, it has been
suggested that a wide CSP may be a non-specific marker for disturbed development
(Bodensteiner and Schaefer, 1990).
We have informally observed enlarged CSP in a large number of children with chromosome
22q11.2 deletion syndrome (22q11.2DS) in the course of collecting and reviewing structural
brain imaging data over the last several years. Van Amelsvoort and others (2001) report a CSP/
CV incidence rate of 40% in adults with 22q11.2DS versus a matched control group. Consistent
with this, Campbell and colleagues (2006) reported a 69% incidence rate of midline anomalies,
in particular those of CSP/CV, in children with 22q11.2DS versus 35% of sibling controls.
Shashi and others (2004) reported the presence of CSP in 4 of 13 children with 22q11.2DS
making it the most common midline brain anomaly in their sample of non-psychotic children
with the chromosomal deletion. 22q11.2DS encompasses the phenotypes of DiGeorge
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(DiGeorge, 1965), velocardiofacial (Shprintzen et al., 1978), and several other syndromes and
is caused by hemizygous 1.5-3.0 Mb interstitial deletions on the q11 band of chromosome 22
(Driscoll et al., 1992). 22q11.2DS prevalence is between 1:2000 and 1:5000 live births
(Oskarsdottir et al., 2004; Shprintzen, 2008) and is characterized by T-cell abnormalities, cleft
palate, heart defects, facial dysmorphisms, and neonatal hypocalcemia (McDonald-McGinn et
al., 1999; Antshel et al., 2005). Impairments or delays in language production and
comprehension, visuospatial and numerical processing (Moss et al., 1999; Swillen et al.,
1999; Bearden et al., 2001; Woodin et al., 2001; Simon et al., 2005a) and executive function
(Sobin et al., 2004; Bish et al., 2005) are common, with mean IQ typically ranging from 70 to
85 (Woodin et al., 2001).
Given our recently stated position that midline anomalies of the brain may be at the root of
many of the cognitive impairments experienced by those with 22q11.2DS (Simon, 2008), it
may be that further understanding of this phenomenon could highlight an important early
detectable biomarker for later neurocognitive dysfunction or even help to explain the
mechanism by which the later impairments are created. However, to the best of our knowledge,
specific quantification of CSP volumetric variability in children with 22q11.2DS has not been
undertaken. Furthermore, most analytical studies of CSP have reported measurements of length
and width (Born et al., 2004; Filipović et al., 2004), but few groups have examined CSP in
volumetric terms (Crippa et al., 2006; Brisch et al., 2007). Since CSP is an anomaly that consists
of a complex three-dimensional volume, strictly linear parameters such as length and width
are unable to fully characterize its extent. Thus, volumetric measurements provide more
accurate information than linear measurements about the true size of the cavum (Crippa et al.,
2006).
The purpose of the current study was to both replicate and extend the existing literature on
brain dysmorphia with a specific focus on CSP in children with 22q11.2DS. To this end, we
used high-resolution magnetic resonance imaging (MRI) to specifically quantify and compare
CSP volumes in children with chromosome 22q11.2DS and TD controls of a similar age. We
hypothesized that CSP would be present more often in children with 22q11.2DS versus TD
children. We also hypothesized that CSP lengths and volumes would be larger in children with
22q11.2DS versus typical controls.
2. Methods
2.1 Participants
Participants were 45 children with 22q11.2DS as confirmed by fluorescence in-situ
hybridization (20 male, 25 female; mean age = 10 yr., 5 mo., SD = 1 yr., 11 mo.) and 35 TD
children (22 males, 13 females; mean age = 10 yr. 10 months, SD = 2 yr., 2 mo.) recruited at
the Children’s Hospital of Philadelphia (CHOP), the Hospital of the University of Pennsylvania
(HUP), and at the University of California, Davis (UCD). After describing the study, assent
was obtained from the child participants and written consent was obtained from guardians as
approved by the Institutional Review Board of CHOP, HUP or UCD., The mean age difference
was not significant between groups (t(78) = 0.98, p = 0.33) and the groups did not significantly
differ in terms of gender composition (χ2(1) = 2.68, p = 0.10). Children recruited at UCD and
HUP were administered the Wechsler Intelligence Scale for Children, version 4 (WISC 4)
(Wechsler, 2003) and children recruited at CHOP were administered the WISC 3 (Wechsler,
1991). As this was a sample of convenience, the Perceptual Organization (PO) from the
WISC-3 and Perceptual Reasoning Index (PRI) from the WISC-4 as well as the Verbal
Comprehension Index (VCI) from the WISC-3 and the VCI from the WISC-4 were treated as
the same measures for the purpose of assessing participants’ cognitive function. IQ measures
were not available for 6 children with chromosome 22q11.2DS and for 9 TD children.
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Mean Full Scale, Verbal (VC or VCI), and Perceptual (PO or PRI) scores were compared
between the 22q11.2DS and TD groups with univariate analyses of variance (ANOVA) with
gender and age in months as covariates. Full scale [F(1,65) = 128.59, p < 0.0001; 22q11.2DS
mean = 76.68, SD = 11.77; TD mean = 110.04, SD = 11.52], Verbal Comprehension [F(1,65)
= 75.37, p < 0.0001; 22q11.2DS mean = 81.12, SD = 13.30; TD mean = 111.32, SD = 14.18],
and Perceptual Organization/Reasoning [F(1,65) = 104.56, p < 0.0001; 22q11.2DS mean =
76.45, SD = 12.55; TD mean = 108.88, SD = 11.63] scores were lower in the 22q11.2DS group
than the TD children. There were no significant effects of gender or age in months on any of
the IQ measures [p values > 0.15].
2.2. Brain image acquisition
This was a retrospective study that aimed to take advantage of a relatively large number of
brain image datasets collected at three separate institutions. Thirty-five scans (n = 18
22q11.2DS, n = 17 TD) were obtained at the Children’s Hospital at Philadelphia, 18 scans (n
= 12 22q11.2DS, n = 6 TD) at the Hospital of the University of Pennsylvania, and 27 scans
(n = 15 22q11.2DS, n = 12 TD) at the University of California, Davis Medical Center. We
acknowledge that there are limitations inherent with combining multi-site data sets. Optimally,
we would have intraclass correlation coefficients for a subgroup of participants or for a single
phantom but given the retrospective nature of the study but this was not possible.
Three-dimensional high-resolution T1-weighted structural scans were acquired using magnetic
resonance imaging (MRI) at three separate institutions. All three sites utilized a magnetization
prepared rapid gradient echo (MP-RAGE) sequence for image acquisition. At the Children’s
Hospital of Philadelphia, a 1.5-T Siemens MAGNETOM Vision scanner (Siemens Medical
Solutions, Erlangen, Germany) was used with the following parameters: repetition time (TR)
= 1.97 s, echo time (TE) = 4 s, flip angle = 12°, number of excitations = 1, matrix size = 256
× 256, slice thickness = 1.0 mm, 160 sagittal slices, in-plane resolution = 1 × 1 mm. At the
Hospital of the University of Pennsylvania, a 3.0-T Siemens MAGNETOM Vision scanner
(Siemens Medical Solutions, Erlangen, Germany) was used with the following parameters: TR
= 1.62 s, TE = 3.87 s, flip angle = 15°, number of excitations = 1, matrix size = 192 × 256,
slice thickness = 1.0 mm, 160 sagittal slices, in-plane resolution = 1 × 1 mm. At the University
of California, Davis, a 3.0-T Siemens MAGNETOM Vision scanner (Siemens Medical
Solutions, Erlangen, Germany) was used with the following parameters: TR = 1.82 s, TE =
2.93 s, flip angle = 12°, number of excitations = 1, matrix size = 256 × 256, slice thickness =
1 mm, 160 sagittal slices, in-plane resolution = 1 × 1 mm.
2.3 Image analysis
Images were transferred to a workstation for preprocessing and analysis. Image sets were
aligned to the anterior commissure and posterior commissure (AC-PC) plane using Analyze
7.5 software (Biomedical Imaging Resource, Mayo Foundation, Rochester, MN). All image
tracing was performed by Y.Q. and V.N. with a high degree of inter-rater reliability on measures
of CSP length (r2 = 0.99, p < 0.0001) and volume (r2 = 0.916, p < 0.0001).
Anteroposterior CSP length can be measured by summing the number of consecutive 1 mm
slices through the coronal plane where a CSP is visible (Nopoulos et al., 2000). For example,
a CSP that could be seen across 6 coronal slices would be approximately 6 mm long. It should
be noted that accurate determination of length might be limited by acquisition of partial image
volumes using this method. Participants’ anteroposterior CSP length was determined using
this method and accordingly, participants where categorized into five groups following
Nopoulos et al. (2000). Categories were defined in terms of the number of 1 mm slices (i.e.
length) visible in the coronal plane. A CSP evident from 1 to 4 slices was labeled Normal; 5
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to 6 slices as Borderline; 7 to 10 slices as Abnormal. If no CSP was evident, these cases where
were labeled as None.
Next, to gain a more accurate measure of CSP volume, the visible CSP area was traced on each
1 mm slice through the coronal plane according to predefined boundaries using Multitracer
(UCLA Laboratory of Neuroimaging, Los Angeles, CA). We operationally defined the
boundaries of the CSP as follows: anteriorly by the genu of the corpus callosum, superiorly by
the body of the corpus callosum, posteriorly by the anterior limb and pillars of the fornix, and
inferiorly by the rostrum of the corpus callosum and the anterior commissure. When viewed
in the coronal plane, the cavum is triangular with its base at the corpus callosum (Born et al.,
2004). Voxels within the tracing boundaries for each slice were then summed to calculate
volume in mm3.
3. Results
3.1 Prevalence of CSP
3.1.1 Prevalence by group and gender—The proportion children with CSP of any size
was greater in children with 22q11.2DS (38 out of 45; 84.4%; χ2 (1) = 7.36, p = 0.007) versus
TD controls (20 out of 35; 57.1%). The overall proportion of having any CSP did not
statistically differ (χ2 (1) = 0.076, p = 0.78) between males (31 out of 42; 73.8%) and females
(27 out of 38; 71.1%). Within each group, the proportion of males to females with any CSP
did not differ from expectation in the 22q11.2DS (χ2 (1) = 0.85, p = 0.44) or TD (χ2 (1) = 0.57,
p = 0.72) groups. There was also no effect of gender on severity of CSP within the 22q11.2DS
(χ2 (5) = 2.13, p = 0.71) or TD (χ2 (3) = 2.04, p = 0.56) groups.
3.1.2 Prevalence by classification—In the course of analyzing the images, we extended
the classification scheme by Nopoulous et al. (2000) to include an Extreme category of CSP
that is twice the anteroposterior length of the upper value of the Borderline classification (i.e.,
12 mm or greater). These extremely large CSP (ranging from 12 to as much as 58 mm in length)
occurred in 11 out of 45 of the 22q11.2DS group. Given that this was seen in 24.4% of our
22q11.2DS sample, we felt that this length range, albeit extreme, should be considered as a
new category of CSP rather than as a set of outliers whose relevance is not considered further.
In fact, the percentage of children with 22q11.2DS in the Extreme category was second only
to those in the Normal category. Example images of each classification category are shown in
Figure 1.
The proportion and frequencies of individuals that fell into the None, Normal, Borderline,
Abnormal, and Extreme categories are shown in Table 1. There was a significant relationship
between group and overall CSP classification (χ2 (4) = 13.00, p = 0.009). There was no
detectable CSP in 15.6% (7/45) of the 22q11.2DS group compared to 42.9% (15/35) of the TD
group, and it was statistically more likely that a TD participant would fall into the None CSP
classification (χ2 (1) = 4.90, p = 0.027). We detected the Normal variant CSP in 44.4% (20/45)
of the 22q11.2DS children and in 37.1% (13/35) of the TD group and the groups did not differ
in the likelihood of this classification (χ2 (1) = 0.025, p = 0.87). Borderline CSP was present
in 4.4% (2/45) of the 22q11.2DS and 11.4% (4/35) of the TD group, and this proportion was
also not significantly different (χ2 (1) = 1.38, p = 0.24) between groups. Children with
22q11.2DS were no more likely to possess an Abnormal CSP (χ2 (1) = 0.71, p = 0.40) than TD
children with 11.1% (5/45) of the 22q11.2DS and 8.6% (3/35) of the TD group meeting the
Abnormal threshold. None of the TD children met the Extreme CSP criteria whereas 24.4%
(11/45) of the children with 22q11.2DS had CSP 12 mm or longer indicating a statistically
significant difference in the likelihood of CSP classification in the Extreme category (χ2 (1) =
7.42, p = 0.06).
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3.2 CSP morphometry
3.2.1 CSP Lengths—The anteroposterior CSP lengths (i.e. sum of 1 mm slices where CSP
was evident) were compared between TD children (M = 2.31; SD = 2.60) and those with
22q11.2DS (M = 12.58; SD = 18.64) controlling for gender, age, and scanner site using analysis
of variance (ANOVA) revealing a significant main effect of Group [F(1) = 10.11, p = 0.002].
There were no significant effects of age [F(1) = 0.58, p = 0.45], gender [F(1) = 0.011, p =
0.92], or scanner site [F(1) = 0.12, p = 0.73]. Box plots of mean log-transformed CSP length
by group are illustrated in Figure 2a.
3.2.2 CSP volumes—Mean CSP volumes were calculated for children with 22q11.2DS
(N = 45; M = 916.13 mm3; SD = 2413.68) and TD (N = 35; M = 12.83 mm3; SD = 19.21)
children. Since CSP volumes ranged from 0 to 13054 mm3 and the distribution of volumes
was extremely negatively skewed [skewness = 4.89, SE = 0.27], parametric analyses were not
possible. Thus, we log transformed CSP values. Cava were larger in the 22q11.2DS group than
in the TD group. Univariate ANOVA comparing logCSP volumes across Groups (22q11.2DS,
TD) while controlling for gender, age in months, and scanner site revealed a significant main
effect of Group [F(1, 75) = 14.93, p < 0.001]. There were no significant effects of age [F(1,75)
= 1.30, p = 0.26], gender [F(1, 75) = 0.10, p = 0.75], or scanner site [F(1, 75) = 1.17, p = 0.28]
in relation to CSP volume. Univariate ANOVA comparing overall log-transformed volumes
across scanner sites did not indicate a statistically significant difference [F(2,79) = 1.16, p =
0.32]. Box plots of mean log-transformed CSP volume by group are illustrated in Figure 2b.
3.3 CSP and IQ
Potential relationships between IQ measures and log-transformed CSP volumes in each group
was investigated using partial correlation controlling for gender and age in months. For the
22q11.2DS group, log-transformed CSP volume was not correlated with FSIQ [r2(32) = 0.07,
p = 0.68], VC/VCI [r2(32) = 0.04, p = 0.82], or PO/PRI [r2(32) = 0.07, p = 0.69]. For the TD
children, log-transformed CSP volume was not correlated with FSIQ [r2(44) = −0.07, p = 0.64],
VC/VCI [r2(44) = −0.10, p = 0.54], or PO/PRI [r2(44) = 0.16, p = 0.92]. We also compared
mean FSIQ, VIQ, and PIQ scores between the 11 children with 22q11.2DS who had extremely
large CSP and the 34 other children with 22q11.2DS. No significant differences on any of the
IQ measures was evident between the Extreme CSP subgroup and the other children with
22q11.2DS even when accounting for unequal group sizes using Welsh’s modification of
Student’s t-test.
4. Discussion
Here, we report a detailed analysis of cavum septum pellucidum in children with chromosome
22q11.2 deletion syndrome in comparison to typically developing controls including, for the
first time, volumetric CSP measurements. Consistent with the only previous report on CSP
incidence in children with 22q11.2DS (Campbell et al., 2006), we found that atypical CSP
length occurs with significantly greater frequency in children with 22q11.2DS than in TD
controls. Based on the CSP classification scheme we used, children with 22q11.2DS and TD
children did not differ in incidence of Normal or Borderline CSP variants. CSP in children
with 22q11.2DS were more likely to be classified as Abnormal or Extreme than TD children.
Mean CSP volumes were significantly larger in children with 22q11.2DS. However, it is noted
that 11 children with very large CSP volumes ranging from 66 to 13054 mm3 accounted for
much of the groups’ differences. The very large CSP volumes were, however, only seen in the
22q11.2DS group. It is difficult to say whether these very large CSP volumes are representative
of a very broad continuous distribution as only the most extreme volume (i.e. 13054 mm3) falls
outside the upper quartile when log-transformed. However, given that 11 out of 45 or 24.4
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percent of children with 22q11.2DS in our study fell under the Extreme CSP designation, we
feel that these are clearly not outliers. Possibly, these 8 children represent a distinct variant
within the 22q11.2DS neurocognitive endophenotype. Nevertheless, hemizygous deletion of
chromosome 22q11.2 is neither necessary nor sufficient to explain the presence of even an
unusually large CSP given that 7 TD children had Borderline or Abnormal CSP and 7 children
with 22q11.2DS had no measurable CSP in the present sample.
How might CSP be maintained in children with 22q11.2DS?
Likely contributing factors include a generally decreased cerebral cortical mass which does
not exert enough medial force combined with diminished downward pull exerted by smaller
temporal lobe structures such as the hippocampus. Overall brain volume in children with
22q11.2DS is between 8 and 11% smaller than TD children, with reductions in both white and
grey matter (Eliez et al., 2000; Kates et al., 2001; Simon et al., 2005b; Campbell et al., 2006)
and specific volume reductions in the hippocampus (Eliez et al., 2001; DeBoer et al., 2007)
and thalamus (Bish et al., 2004). Whole brain tissue volume reductions are accompanied by
enlarged lateral ventricles (Simon et al., 2005b) and enlarged ventricles have been associated
with displacement of the corpus callosum (Simon et al., 2005b). The hippocampus is attached
to the fornix through the alveus, which is pulled backward and downward with hippocampal
development. Lower mass from the developing hippocampi and proximal temporal lobe
structures (e.g. amygdalae, parahippocampal gyri) may not be great enough to adequately pull
the inferior leaflets of the septum pellucidum into apposition via a tractional effect on the fornix.
The lower average masses of temporal lobe structures may thus help explain the greater
incidence of CSP in children with 22q11.2DS versus TD children.
What are the functional implications of enlarged CSP?
It is well known that 22q11.2DS confers one of the highest genetic risks of developing
schizophrenia (Murphy, 1999), a condition in which CSP has been extensively investigated
(e.g. Kwon et al., 1998; Nopoulos et al., 2000; Filipović et al., 2004). Given the high incidence
of CSP in patients with schizophrenia, surveying abnormalities in brain morphometry in
childhood may help to characterize a “high-risk” endophenotype in children with 22q11.2DS.
However, it has been shown that the presence of a large CSP does not distinguish patients with
schizophrenia who have (van Amelsvoort et al., 2004) or who do not have (Flashman et al.,
2007; Takahashi et al., 2007) 22q11.2DS from TD controls. Large CSP was, however,
associated with volume reductions in left parahippocampal gyrus and bilateral amygdalae in
participants with schizophrenia but not in healthy controls (Takahashi et al., 2007). In females
with schizotypal personality disorder, both larger CSP and smaller hippocampi have been noted
(Dickey et al., 2007) further suggesting a contributing role of abnormal hippocampal
development in the development and maintenance of CSP. While there is a diathesis conferred
via this chromosomal deletion, the likelihood of psychosis in young adulthood is clearly
modulated by a multitude of variables. Standardized IQ measures can be a proxy measure of
global intellectual function but we did not find any relationships between CSP incidence or
size and intellectual ability. Thus, it appears that enlarged CSP, while reflecting anomalous
midline brain development, does not necessarily reflect poorer brain function.
In summary, we used a slice-by-slice image tracing approach to accurately characterize CSP
volumetric variability in a fairly large sample of children with 22q11.2DS. We replicated the
single previous report of high rates of CSP in children affected by the deletion. We extended
existing knowledge by showing that the most common category of abnormal CSP in children
with 22q11.2DS is the new category that we labeled Extreme. CSP of this size have typically
been set aside as outliers in other studies and, while that label may be appropriate for
populations where relatively small enlargements occur, we present the view that it is not valid
in the case of 22q11.2DS. The presence of an enlarged CSP was not predictive of intellectual
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ability in the current study and may be more indicative of anomalous brain development rather
than predictive of functional impairment. Nevertheless, 22q11.2DS confers a 25-30 fold
increased risk for developing schizophrenia versus the general population and the brains of
children with 22q11.2DS and adults with schizophrenia share a number of morphological
similarities, including enlarged CSP. Further studies into the maintenance of CSP and
development of proximal brain structures are an important avenue for future investigation
especially in older children who may be displaying symptoms prodromal to conversion to a
psychotic disorder.
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Figure 1.
A composite of coronal and axial T1-weighted anatomical magnetic resonance (MR) images
illustrating an example from each of the five CSP classifications used in this study: A = None,
B = Normal, C = Borderline, D = Abnormal, and E = Extreme. Note the complete nonfusion
of the septal leaflets in E showing the presence and severe enlargement of cavum septum
pellucidum/cavum verga in a patient with chromosome 22q11.2 deletion syndrome.
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Figures 2a and 2b.
Boxplots of log-transformed CSP lengths (2a) and volumes (2b) for children with and without
chromosome 22q11.2 deletion syndrome (22q11.2DS). Data points are labeled according to
the CSP classification scheme. Note the number of CSP volumes that fell beyond the fourth
quartile of the boxplot in the group of children with 22q11.2DS.
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